|
HELB expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.30320000013562E-07 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.85399999996783E-06 |
| Normal-vs-Stage2 |
3.56189999717316E-09 |
| Normal-vs-Stage3 |
6.21450000348744E-08 |
| Normal-vs-Stage4 |
3.41420003380222E-09 |
| Stage1-vs-Stage2 |
1.843360E-03 |
| Stage1-vs-Stage3 |
5.709500E-02 |
| Stage1-vs-Stage4 |
1.379290E-03 |
| Stage2-vs-Stage3 |
1.940000E-01 |
| Stage2-vs-Stage4 |
8.801200E-01 |
| Stage3-vs-Stage4 |
2.217800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.70720000031355E-07 |
| Normal-vs-AfricanAmerican |
4.368500E-04 |
| Normal-vs-Asian |
1.15970000047483E-07 |
| Caucasian-vs-AfricanAmerican |
3.743200E-01 |
| Caucasian-vs-Asian |
2.279600E-01 |
| AfricanAmerican-vs-Asian |
8.956300E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.38819999729157E-09 |
| Normal-vs-Female |
5.46780000054703E-07 |
| Male-vs-Female |
4.443600E-03 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.36169999995517E-06 |
| Normal-vs-Age(41-60Yrs) |
9.24840000138261E-08 |
| Normal-vs-Age(61-80Yrs) |
2.0282999946275E-08 |
| Normal-vs-Age(81-100Yrs) |
5.63820000000215E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.718400E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.555980E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.244600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.909000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.250600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.430800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.391250E-01 |
| Classical-VS-Follicular |
1.030390E-01 |
| Classical-VS-Other |
1.219050E-01 |
| Classical-VS-Normal |
9.00029999972851E-07 |
| Tall-VS-Follicular |
8.264600E-01 |
| Tall-VS-Other |
4.613400E-01 |
| Tall-VS-Normal |
5.6550000004929E-07 |
| Follicular-VS-Other |
4.413400E-01 |
| Follicular-VS-Normal |
1.03149999985952E-07 |
| Other-VS-Normal |
3.72260000000013E-05 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.77649999552909E-08 |
| Normal-vs-N1 |
2.21730000027343E-07 |
| N0-vs-N1 |
8.778000E-01 |
|
|
